Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
allergic to the vaccine; This serious case was reported by a consumer via interactive digital media and described the occurrence of allergy to vaccine in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced allergy to vaccine (Verbatim: allergic to the vaccine) (serious criteria other: Serious as per reporter). The outcome of the allergy to vaccine was unknown. It was unknown if the reporter considered the allergy to vaccine to be related to Shingrix. The company considered the allergy to vaccine to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 09-SEP-2025 This case was reported by a patient via interactive digital media. The patient had told numerous people that he/she was allergic to the vaccine and had been instructed by his/her physician not to take the second one. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Allergy to vaccine, an unknown time after receiving Shingrix, in a patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.